About Ardelyx (ARDX)
Ardelyx, Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutics focuses on addressing cardiorenal and gastrointestinal (GI) diseases. It operates through the research, development and commercialization of biopharmaceutical pro... Read more
- USD3.58
- USD3.71
- USD3.56
- USD8.14
- -19.60%
- 362M
- 5.44M
- 6.46M
- 988M
- 3.50
- -55.10%
Stock News
2 hours ago
FAA weighs reducing Newark flights after hundreds of disruptions
CNBC
2 hours ago
Lutnick says 10% baseline tariff will stick around for "foreseeable future"
CNBC
3 hours ago
The ‘most important consumer earnings report of the season’ lands this week
MarketWatch
3 hours ago
People are feeling lousy about work. The internet's career advice expert has some tips
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
